These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Study of the use and therapeutic activity of oenanthate of fluphenazine, a neuroleptic with long-term action, in psychoses in children]. Michaux L; Dugas M; Colomb G; Guériot C Rev Neuropsychiatr Infant; 1971 Jun; 19(6):351-9. PubMed ID: 5564560 [No Abstract] [Full Text] [Related]
4. [Importance of delayed-action compounds for management of neuroleptic treatments. (Apropos of fluphenazine enanthate)]. Delay J; Deniker P; Perier M; Dalle B Presse Med (1893); 1967 May; 75(24):1243-6. PubMed ID: 6024177 [No Abstract] [Full Text] [Related]
5. [Use of fluphenazine oenanthate in psychiatric therapy (personal experience)]. Darcourt G; Lavagna J; Myquel M; Bècle J Ann Med Psychol (Paris); 1971 Oct; 2(3):448-59. PubMed ID: 5128638 [No Abstract] [Full Text] [Related]
7. [Use of Lyogen in the treatment of mental diseases in children]. Sternalski M Przegl Lek; 1970 Mar; 26(3):403-4. PubMed ID: 5443568 [No Abstract] [Full Text] [Related]
8. Medical management of the psychotic syndrome. Yorke ET Dis Nerv Syst; 1966 Apr; 27(4):252-6. PubMed ID: 5936138 [No Abstract] [Full Text] [Related]
9. [Treatment of mental problems in prisons. Therapy of psychogenic disorders using depot-psychopharmacological agents]. Last G Ther Ggw; 1974 Apr; 113(4):595 passim. PubMed ID: 4832534 [No Abstract] [Full Text] [Related]
10. [Importance of delayed-action neuroleptics]. Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert Ann Med Psychol (Paris); 1969 May; 1(5):772-8. PubMed ID: 5398062 [No Abstract] [Full Text] [Related]
11. [Importance of delayed-action neuroleptics]. Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert Ann Med Psychol (Paris); 1969 May; 127(5):772-8. PubMed ID: 5397523 [No Abstract] [Full Text] [Related]
12. [Physician-patient relation under delayed-action neuroleptic]. Ostaptzeff G; Ostaptzeff-Lavoine ; Noël-Degraève F Ann Med Psychol (Paris); 1969 Nov; 2(4):564-7. PubMed ID: 5392722 [No Abstract] [Full Text] [Related]
13. [Therapeutic management, the hospital environment]. Gayral L Encephale; 1970; ():Suppl:19-25. PubMed ID: 5458709 [No Abstract] [Full Text] [Related]
14. The use of fluphenazine in the long-term management of outpatients with refractory psychiatric illnesses. McLaughlin BE Psychosomatics; 1966; 7(6):357-63. PubMed ID: 5979975 [No Abstract] [Full Text] [Related]
15. [Electroencephalographic effects of fluphonazine decanoate]. Borenstein P; Cujo P; Dumaine A Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414 [No Abstract] [Full Text] [Related]
16. The effects of long-term use of fluphenazine in non-hospitalized patients with mental and emotional disorders. Marrow LE Psychosomatics; 1965; 6(5):371-4. PubMed ID: 5319252 [No Abstract] [Full Text] [Related]
17. Symposium on long-acting phenothiazines in psychiatry. Introduction. Cole JO Dis Nerv Syst; 1970 Sep; 31():Suppl:5. PubMed ID: 5476360 [No Abstract] [Full Text] [Related]
18. Fluphenazine ("anatensol") in the treatment of disturbed mentally retarded children. Burness FR Med J Aust; 1968 Feb; 1(6):241. PubMed ID: 5641732 [No Abstract] [Full Text] [Related]
19. Large doses of fluphenazine enanthate. Simpson GM Br Med J; 1972 Jul; 3(5821):293-4. PubMed ID: 5046497 [No Abstract] [Full Text] [Related]
20. [The course of long-term care with fluphenazine decanoate (Dapotum D)]. Deiser R; Schindler R Psychiatr Clin (Basel); 1980; 13(3-4):193-205. PubMed ID: 6787668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]